“There’s not an aspect of lung cancer care in which there’s not a significant disparity that hinders the ability of minority patients to get better care,” says Olugbenga Okusanya, MD, of Thomas Jefferson University in Philadelphia.
“Black patients are less likely to get surgical therapy for early-stage disease, which is the actual cure for early-stage disease. They are also less likely to get chemotherapy and be enrolled in clinical trials.”
“It’s really disheartening to see this. There are lots of patients who have good options that never get them.”
A 2-minute video from the Patient Empowerment Network